Page 117 - AIH-2-1
P. 117

Artificial Intelligence in Health                      ML approach for client and program effects in OUD retention



            percentages of Black staff, can positively impact retention   Ethics approval and consent to participate
            rates among Black clients in opioid treatment programs
            (OTPs).  This underscores  the  importance  of employing   This study was reviewed and approved by the Institutional
            advanced statistical methods to identify and quantify when   Review Board of Texas A&M University (TAMU
            and how diversity enhances treatment outcomes, especially   IRB#2019-0268DCR).
            for minority clients. By doing so, we can better address   Consent for publication
            the unique needs of these clients and optimize program
            resources to serve minority communities effectively.  Not applicable.
              As federal and state authorities prepare to allocate   Availability of data
            substantial financial resources from various sources
            – including pharmaceutical settlements and new tax   Not applicable.
            revenues – to improve access to opioid treatment, 33,34  it   References
            is imperative to understand how these investments can
            best support OTPs in enhancing overall patient outcomes.   1.   CDC/National Center for Health Statistics. U.S. Overdose
            This is particularly vital for improving outcomes among   Deaths Decrease in 2023, First Time Since 2018; 2024.
            minority populations, who often face additional barriers   Available  from:  https://www.cdc.gov/nchs/pressroom/
            to accessing quality care. A  diverse workforce not only   nchs_press_releases/2024/20240515.htm [Last accessed on
                                                                  2024 May 24].
            reflects the communities these programs serve but also
            has the potential to foster a more inclusive and supportive   2.   Bart G. Maintenance medication for opiate addiction: The
            treatment environment that can significantly impact   foundation of recovery. J Addict Dis. 2012;31(3):207-225.
            retention and recovery. Therefore, fully leveraging the      doi: 10.1080/10550887.2012.694598
            benefits of workforce diversity will be crucial in shaping   3.   Chan B, Gean E, Arkhipova-Jenkins  I,  et al. Retention
            policies and interventions that maximize the effectiveness   strategies for medications for opioid use disorder in adults.
            of opioid treatment programs, especially in underserved   J Addict Med. 2020;15(1):74-84.
            and minority communities.
                                                                  doi: 10.1097/adm.0000000000000739
            Acknowledgments                                    4.   Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-
            The authors would like to thank Joanna Mendoza, from   Diehn C. Retention in medication-assisted treatment for
            Texas A&M University, for editing and proofreading this   opiate dependence: A  systematic review.  J  Addict Dis.
                                                                  2015;35(1):22-35.
            manuscript.
                                                                  doi: 10.1080/10550887.2016.1100960
            Funding                                            5.   Williams AR, Samples H, Crystal S, Olfson M. Acute
            Support for this research and manuscript preparation   care,  prescription opioid  use,  and overdose following
            was provided by a National Institute on Minority Health   discontinuation of long-term buprenorphine treatment for
            and  Health  Disparities  research  grant  (R01MD014639,   opioid use disorder. Am J Psychiatry. 2020;177(2):117-124.
            CoPIs: Daniel Howard and Erick Guerrero) and a National      doi: 10.1176/appi.ajp.2019.19060612
            Institute on Drug Abuse research grant (DA048176, CoPIs:   6.   Carroll KM, Weiss RD. The role of behavioral interventions
            Jeanne Marsh and Erick Guerrero).                     in buprenorphine maintenance treatment: A review. Am J
            Conflict of interest                                  Psychiatry. 2017;174(8):738-747.
                                                                  doi: 10.1176/appi.ajp.2016.16070792
            The authors declare they have no competing interests.
                                                               7.   Manhapra A, Petrakis I, Rosenheck R. Three-year retention
            Author contributions                                  in buprenorphine treatment for opioid use disorder
                                                                  nationally in the Veterans health administration.  Am J
            Conceptualization: Yinfei Kong, Erick Guerrero        Addict. 2017;26(6):572-580.
            Formal analysis: Yinfei Kong, Erick Guerrero, Suojin Wang
            Investigation: Yinfei Kong, Erick Guerrero, Suojin Wang     doi: 10.1111/ajad.12553
            Methodology: Yinfei Kong, Suojin Wang              8.   Proctor SL, Copeland AL, Kopak AM, Hoffmann NG,
            Writing – original draft: Yinfei Kong, Erick Guerrero  Herschman PL, Polukhina N. Predictors of patient retention
            Writing – review & editing:  Jemima A. Frimpong, Tenie   in methadone maintenance treatment. Psychol Addict Behav.
               Khachikian, Suojin Wang, Thomas D’Aunno, Daniel    2015;29(4):906-917.
               Howard                                             doi: 10.1037/adb0000090


            Volume 2 Issue 1 (2025)                        111                               doi: 10.36922/aih.3750
   112   113   114   115   116   117   118   119   120   121   122